31 May 2011 Business
Industry news, June 2011
GlaxoSmithKline (GSK) has agreed to sell drinks brands Lucozade and Ribena to Japanese food and beverage maker Suntory. The £1.35 billion cash deal includes global distribution rights to the brands, together with the associated manufacturing plant in Coleford, UK, and its employees. GSK will continue to make and sell Ribena and Lucozade in Nigeria under licence from Suntory.
The move is the latest in a series of divestitures, which began in 2011, in which GSK has sold off consumer product and over-the-counter healthcare brands. The company intends to focus on its pharmaceutical and vaccine operations, as well as a narrower portfolio of over-the-counter healthcare products, whose presence it intends to expand in emerging markets.
3 December 2013 Research
Innovative electrodes set to put electric cars in the fast lane with a new design that holds double the energy of ordinary li...
29 November 2013 Research
Gadgets that power themselves by harvesting energy from both light and wind are on the horizon